---
title: "China NT Pharma details board and committee structure"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286043695.md"
description: "China NT Pharma Group Co., Ltd. has announced the structure of its board of directors, which includes executive, non-executive, and independent non-executive members, led by chairman Mr. Ng Tit. The company also detailed its three key board committees: audit, remuneration, and nomination, with leadership concentrated among independent non-executive directors to enhance governance and oversight. The company, listed in Hong Kong under stock code 1011, focuses on drug-related products and services in the Greater China market."
datetime: "2026-05-12T04:40:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286043695.md)
  - [en](https://longbridge.com/en/news/286043695.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286043695.md)
---

# China NT Pharma details board and committee structure

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

An announcement from China NT Pharma Group Co., Ltd. ( (HK:1011) ) is now available.

China NT Pharma Group Co., Ltd., a Cayman Islands–incorporated pharmaceutical company listed in Hong Kong under stock code 1011, has outlined the composition of its board of directors, including executive, non-executive and independent non-executive members. The board is led by chairman Mr. Ng Tit and includes Ms. Ng Anna Ching Mei, Dr. Qian Wei, Ms. Chin Yu, Mr. Lou Yongbin, Mr. Yu Tze Shan Hailson, Dr. Zhao Yubiao and Mr. Kwok Che Chung.

The company also detailed membership of its three key board committees: the audit committee, the remuneration committee and the nomination committee. Committee leadership is concentrated among the independent non-executive directors, indicating an emphasis on governance and oversight, with specific roles allocated to ensure checks and balances across financial reporting, pay structures and board appointments as part of its corporate governance framework.

**More about China NT Pharma Group Co., Ltd.**

China NT Pharma Group Co., Ltd. is a pharmaceutical company listed in Hong Kong under stock code 1011 and incorporated in the Cayman Islands with limited liability. The group operates in the healthcare and pharmaceuticals sector, focusing on drug-related products and services within the Greater China market and beyond, serving hospitals, healthcare providers and patients.

**Average Trading Volume:** 322,111

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$597.9M

For a thorough assessment of 1011 stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [01011.HK](https://longbridge.com/en/quote/01011.HK.md)

## Related News & Research

- [China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen](https://longbridge.com/en/news/286577625.md)
- [China NT Pharma Calls 2026 AGM, Seeks Renewal of Share Issuance Mandate](https://longbridge.com/en/news/284750140.md)
- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [Moberg Pharma names Lars Johansson chairman, adds three new board members](https://longbridge.com/en/news/287225517.md)
- [<![CDATA[Pharmaceutical Executive Daily: TrumpRx Expands to Offer Over 600 Generic Drugs]]>](https://longbridge.com/en/news/286948461.md)